QQ客服 官方微博 反馈留言

	Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients
	Liao, Li; Yu, Huajian; Ge, Mengxi; Zhan, Qiong; Huang, Ruofan; Ji, Xiaoyu; Liang, Xiaohua; Zhou, Xinli
刊名	THORACIC CANCER
	2019
卷号	10期号:5
关键词	AKT AMPK signaling pathway metastasis NSCLC proliferation PSPH
ISSN号	1759-7706
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3598987
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liao, Li,Yu, Huajian,Ge, Mengxi,et al. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients[J]. THORACIC CANCER,2019,10(5).
APA	Liao, Li.,Yu, Huajian.,Ge, Mengxi.,Zhan, Qiong.,Huang, Ruofan.,...&Zhou, Xinli.(2019).Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.THORACIC CANCER,10(5).
MLA	Liao, Li,et al."Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients".THORACIC CANCER 10.5(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。